Copyright © 1986 by the European Society of Cardiology.
© 1986 The European Society of Cardiology
Effect of sotalol, aprindine and the combination aprindinesotalol on monophasic action potential duration




*Department of Cardiology, St.-Jozef Hospital Oostende, Belgium
Abteilung Innere Medizin III (Kardiologie), Medizinische Universitätsklinik Heidelberg, F.R.G.
Department of Cardiology the St.-Rafael University Hospital Leuven, Belgium
Received 18 March 1985; revised 19 August 1985; .
R. Stroobandt, MD, Dept. Cardiology, St.-Jozef Hospital, B-8400 Oostende, Belgium
Abstract
The effects of sotalol, aprindine and the combination aprindine-sotalol in the intact dog heart were evaluated during constant atrial pacing with the use of monophasic action potential (MAP) recording. A first group of five dogs was given 1.5 mg kg1 body weight of sotalol, followed by a second infusion of 1.5 mg kg1 30 min later. Both doses of sotalol produced a statistically significant increase in right atrial MAP duration at 50% of repolarization (RAMAP50) and right ventricular MAP duration at 90% of repolarization (RVMAP90). To a second group of six dogs aprindine 1 mg kg1 and aprindine 2 mg kg1 were administered intravenously. The infusion of aprindine did not alter right atrial and right ventricular MAP duration. The addition of 1.5 mg kg1 of sotalol to the dogs pretreated with aprindine 2 mg kg1 resulted a 25% increase in RAMAP50 and a 21% prolongation of RVMAP90. In summary, sotalol lengthens atrial and ventricular monophasic action potential duration and still prolongs repolarization of monophasic action potentials after previous administration of aprindine. A combination of sotalol, a beta-adrenergic blocker possessing class III efficacy, with a class I antiarrhythmic agent may be useful with respect to their electrophysiological action.
Key Words: Sotalol aprindine monophasic action potentials antiarrhythmic drugs